Lin et al. demonstrated that treatment of HCT116 colon cancer cells with glycated BSA increased the expression of RAGE and boosted malignancy via MAPK/NF-κB-induced STAT3 and β-catenin expression [62]. The gene discussed is STAT3; the disease is colonic neoplasm.